Testing a new tool to improve treatment connection for opioid use disorder
Part of Mental health clinical trials.
This study tests a new mobile tool called emPath that helps connect people with opioid use disorder to treatment and support. The goal is to see if using this tool improves how well people stay engaged in care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have used opioids in a way that is moderate or high risk (for example, using more than intended or having cravings)
- You are not currently taking any medication like methadone, buprenorphine, or naltrexone for your opioid use
- You can speak and understand English
- You are willing to agree to take part in the program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding peer recovery support and coordinated opioid treatment support can improve care for people with opioid use disorder (OUD) who are on probation. It also trains and involves probation and treatment staff to better support clients over 12 months.
This study tests whether telehealth can improve treatment for opioid use disorder and related mental health issues, especially for people who face barriers to care. It may help patients stay connected to their buprenorphine treatment from home.
This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This study tests whether a smartphone app and support from a peer recovery coach can help Black and Latinx individuals with opioid use disorder start buprenorphine treatment. The goal is to reduce overdose deaths and address racial gaps in care.
This study tests a digital tool called Compl-AI that aims to predict whether someone with opioid use disorder might stop their medication early. If it works, doctors could step in sooner to help people stay on treatment.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.